Rabies vaccination: Comparison of neutralizing antibody responses after priming and boosting with different combinations of DNA, inactivated virus, or recombinant vaccinia virus vaccines

Vaccine

Volumn 18, Issue 22, 2000, Pages 2394-2398

  Lodmell, Donald L ^a   Ewalt, Larry C ^a  

^a Lab of Persistent Viral Diseases   (United States)

Author keywords

Booster; DNA vaccine; Human diploid cell vaccine (HDCV); Neutralizing antibody; Rabies virus; Recombinant vaccinia virus (RVV) vaccine

Indexed keywords

DIPLOID CELL VACCINE; DNA VACCINE; NEUTRALIZING ANTIBODY; RABIES VACCINE; SMALLPOX VACCINE;

ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RABIES; RABIES VIRUS;

EID: 0034013584     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(00)00005-0     Document Type: Article

References (30)

1. Hanlon C.L., Niezgoda M., Hamir A.N., Schumacher C., Koprowski H., Rupprecht C.E. First North American field release of a vaccinia-rabies glycoprotein recombinant virus. J. Wildlife Dis. 34:1998;228-239.
2. Rupprecht C.E., Wiktor T.J., Johnston D.H., Hamir A.N., Dietzschold B., Wunner W.H., Glickman L.T., Koprowski H. Oral immunization and protection of raccoons (Procyon lotor) with a vaccinia-rabies glycoprotein recombinant virus vaccine. Proc. Natl. Acad. Sci. USA. 83:1986;7947-7950.
3. Rupprecht C.E., Hanlon C.A., Cummins L.B., Koprowski H. Primate responses to a vaccinia-rabies glycoprotein recombinant virus vaccine. Vaccine. 10:(6):1992;368-374.
4. Esposito J.J., Knight J.C., Shaddock J.H., Novembre F.J., Baer G.M. Successful oral rabies vaccination of raccoons with raccoon poxvirus recombinants expressing rabies virus glycoprotein. Virology. 165:1988;313-316.
5. Lodmell D.L., Smith J.S., Esposito J.J., Ewalt L.C. Cross-protection of mice against a global spectrum of rabies virus variants. J. Virol. 69:1995;4957-4962.
6. Lodmell D.L., Sumner J.W., Esposito J.J., Bellini W.J., Ewalt L.C. Raccoon poxvirus recombinants expressing the rabies virus nucleoprotein protect mice against lethal rabies virus infection. J. Virol. 65:1991;3400-3405.
7. Taylor J., Weinberg R., Languet B., Desmettre P., Paoletti E. Recombinant fowlpox virus inducing protective immunity in non-avian species. Vaccine. 6:1988;497-503.
8. Taylor J., Trimarchi C., Weinberg R., Languet B., Guillemin F., Desmettre P., Paoletti E. Efficacy studies on a canarypox-rabies recombinant virus. Vaccine. 9:1991;190-193.
9. Prevec L., Campbell J.B., Christie B.S., Belbeck L., Graham F.L. A recombinant human adenovirus vaccine against rabies. J. Infect. Dis. 161:1990;27-30.
10. Charlton K.M., Artois M., Prevec L., Campbell J.B., Casey G.A., Wandeler A.I., Armstrong J. Oral rabies vaccination of skunks and foxes with a recombinant human adenovirus vaccine. Arch. Virol. 123:1992;169-179.
11. Xiang Z., Ertl H.C. Induction of mucosal immunity with a replication-defective adenoviral recombinant. Vaccine. 17:1999;2003-2008.
12. Lodmell D.L., Ray N.B., Parnell M.J., Ewalt L.C., Hanlon C.A., Shaddock J.H., Sanderlin D.S., Rupprecht C.E. DNA immunization protects nonhuman primates against rabies virus. Nat. Med. 4:1998;949-952.
13. Osorio J.E., Tomlinson C.C., Frank R.S., Haanes E.J., Rushlow K., Haynes J.R., Stinchcomb D.T. Immunization of dogs and cats with a DNA vaccine against rabies virus. Vaccine. 17:1999;1109-1116.
14. Lodmell D.L., Ray N.B., Ewalt L.C. Gene gun particle-mediated vaccination with plasmid DNA confers protective immunity against rabies virus infection. Vaccine. 16:1998;115-118.
15. Ray N.B., Ewalt L.C., Lodmell D.L. Nanogram quantities of plasmid DNA encoding the rabies virus glycoprotein protect mice against lethal rabies virus infection. Vaccine. 15:1997;892-895.
16. Xiang Z.Q., Spitalnik S., Tran M., Wunner W.H., Cheng J., Ertl H.C. Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. Virology. 199:1994;132-140.
17. Xiang Z.Q., Spitalnik S.L., Cheng J., Erikson J., Wojczyk B., Ertl H.C. Immune responses to nucleic acid vaccines to rabies virus. Virology. 209:1995;569-579.
18. Esposito J., Brechling K., Baer G., Moss B. Vaccinia virus recombinants expressing rabies virus glycoprotein protect against rabies. Virus Genes. 1:1987;7-21.
19. Zhao W.G., Azaibi T., Zhu J.H., Wang J.L., Cai B., Esposito J.J. Co-expression of rabies virus glycoprotein and nucleoprotein in vaccinia virus Tian Tan strain. Virol. Senica. 10:1995;15-21.
20. Smith J.S., Yager P.A., Baer G.M. A rapid reproducible test for determining rabies neutralizing antibody. Bull. WHO. 48:1973;535-541.
21. Perry L.L., Lodmell D.L. Role of CD4+ and CD8+ T cells in murine resistance to street rabies virus. J. Virol. 65:1991;3429-3434.
22. Kundig T.M., Kalberer C.P., Hengartner H., Zinkernagel R.M. Vaccination with two different vaccinia recombinant viruses: long-term inhibition of secondary vaccination. Vaccine. 11:1993;1154-1158.
23. Belyakov I.M., Moss B., Strober W., Berzofsky J.A. Mucosal vaccination overcomes the barrier to recombinant vaccinia immunization caused by preexisting poxvirus immunity. Proc. Natl. Acad. Sci. USA. 96:1999;4512-4517.
24. Demkowicz W.E.J., Littaua R.A., Wang J., Ennis F.A. Human cytotoxic T-cell memory: long-lived responses to vaccinia virus. J. Virol. 70:1996;2627-2631.
25. Sedegah M., Jones T.R., Kaur M., Hedstrom R., Hobart P., Tine J.A., Hoffman S.L. Boosting with recombinant vaccinia increases immunogenicity and protective efficacy of malaria DNA vaccine. Proc. Natl. Acad. Sci. USA. 95:1998;7648-7653.
26. Li S., Rodrigues M., Rodriguez D., Rodriguez J.R., Esteban M., Palese P., Nussenzweig R.S., Zavala F. Priming with recombinant influenza virus followed by administration of recombinant vaccinia virus induces CD8+ T-cell-mediated protective immunity against malaria. Proc. Natl. Acad. Sci. USA. 90:1993;5214-5218.
27. Schneider J., Gilbert S.C., Blanchard T.J., Hanke T., Robson K.J., Hannan C.M., Becker M., Sinden R., Smith G.L., Hill A.V. Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara. Nat. Med. 4:1998;397-402.
28. Hanke T., Blanchard T.J., Schneider J., Hannan C.M., Becker M., Gilbert S.C., Hill A.V., Smith G.L., McMichael A. Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime. Vaccine. 16:1998;439-445.
29. Caver T.E., Lockey T.D., Srinivas R.V., Webster R.G., Hurwitz J.L. A novel vaccine regimen utilizing DNA, vaccinia virus and protein immunizations for HIV-1 envelope presentation. Vaccine. 17:1999;1567-1572.
30. Robinson H.L., Montefiori D.C., Johnson R.P., Manson K.H., Kalish M.L., Lifson J.D., Rizvi T.A., Lu S., Hu S.L., Mazzara G.P., Panicali D.L., Herndon J.G., Glickman R., Candido M.A., Lydy S.L., Wyand M.S., McClure H.M. Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations [see comments]. Nat. Med. 5:1999;526-534.